These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31057085)

  • 41. Vasopressors for the Treatment of Septic Shock: Systematic Review and Meta-Analysis.
    Avni T; Lador A; Lev S; Leibovici L; Paul M; Grossman A
    PLoS One; 2015; 10(8):e0129305. PubMed ID: 26237037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
    Shankar-Hari M; Phillips GS; Levy ML; Seymour CW; Liu VX; Deutschman CS; Angus DC; Rubenfeld GD; Singer M;
    JAMA; 2016 Feb; 315(8):775-87. PubMed ID: 26903336
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding vasoactive medications: focus on pharmacology and effective titration.
    Allen JM
    J Infus Nurs; 2014; 37(2):82-6. PubMed ID: 24583937
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock.
    Vail E; Gershengorn HB; Hua M; Walkey AJ; Rubenfeld G; Wunsch H
    JAMA; 2017 Apr; 317(14):1433-1442. PubMed ID: 28322415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS).
    Jeon K; Song JU; Chung CR; Yang JH; Suh GY
    Crit Care; 2018 May; 22(1):131. PubMed ID: 29784057
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
    Chawla LS; Ostermann M; Forni L; Tidmarsh GF
    Crit Care; 2019 Apr; 23(1):124. PubMed ID: 30992045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vasopressor and inotrope treatment for septic shock: An umbrella review of reviews.
    Einav S; Helviz Y; Ippolito M; Cortegiani A
    J Crit Care; 2021 Oct; 65():65-71. PubMed ID: 34090150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.
    Daley MJ; Lat I; Mieure KD; Jennings HR; Hall JB; Kress JP
    Ann Pharmacother; 2013 Mar; 47(3):301-10. PubMed ID: 23447481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent Updates in the Pharmacological Management of Sepsis and Septic Shock: A Systematic Review Focused on Fluid Resuscitation, Vasopressors, and Corticosteroids.
    Allen JM; Feild C; Shoulders BR; Voils SA
    Ann Pharmacother; 2019 Apr; 53(4):385-395. PubMed ID: 30404539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
    Russell JA; Lee T; Singer J; De Backer D; Annane D
    J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasopressors During Sepsis: Selection and Targets.
    Gelinas JP; Russell JA
    Clin Chest Med; 2016 Jun; 37(2):251-62. PubMed ID: 27229642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controversies regarding choice of vasopressor therapy for management of septic shock in animals.
    Silverstein DC; Beer KA
    J Vet Emerg Crit Care (San Antonio); 2015; 25(1):48-54. PubMed ID: 25655726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multi-complexity measures of heart rate variability and the effect of vasopressor titration: a prospective cohort study of patients with septic shock.
    Brown SM; Sorensen J; Lanspa MJ; Rondina MT; Grissom CK; Shahul S; Mathews VJ
    BMC Infect Dis; 2016 Oct; 16(1):551. PubMed ID: 27724850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis.
    Meier-Hellmann A; Specht M; Hannemann L; Hassel H; Bredle DL; Reinhart K
    Intensive Care Med; 1996 Dec; 22(12):1354-9. PubMed ID: 8986486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Delayed vasopressor initiation is associated with increased mortality in patients with septic shock.
    Colon Hidalgo D; Patel J; Masic D; Park D; Rech MA
    J Crit Care; 2020 Feb; 55():145-148. PubMed ID: 31731173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
    Carr AC; Shaw GM; Fowler AA; Natarajan R
    Crit Care; 2015 Nov; 19():418. PubMed ID: 26612352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Vasopressors: Physiology, Pharmacology and Clinical Applications].
    Keller M; Magunia H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2021 Jun; 56(6):400-413. PubMed ID: 34187073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vasopressor effects on venous return in septic patients: a review.
    Feldheiser A; Gelman S; Chew M; Stopfkuchen-Evans M
    Eur J Anaesthesiol; 2021 Jun; 38(6):659-663. PubMed ID: 33927104
    [No Abstract]   [Full Text] [Related]  

  • 59. Practice Patterns and Outcomes Associated With Choice of Initial Vasopressor Therapy for Septic Shock.
    Fawzy A; Evans SR; Walkey AJ
    Crit Care Med; 2015 Oct; 43(10):2141-6. PubMed ID: 26079345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Norepinephrine Infusion in the Emergency Department in Septic Shock Patients: A Retrospective 2-Years Safety Report and Outcome Analysis.
    Messina A; Milani A; Morenghi E; Costantini E; Brusa S; Negri K; Alberio D; Leoncini O; Paiardi S; Voza A; Cecconi M
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33478004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.